Literature DB >> 28192718

Quantitative determination of five metabolites of aspirin by UHPLC-MS/MS coupled with enzymatic reaction and its application to evaluate the effects of aspirin dosage on the metabolic profile.

Jian-Ping Li1, Jian-Ming Guo2, Er-Xin Shang1, Zhen-Hua Zhu1, Yang Liu1, Bu-Chang Zhao3, Jing Zhao3, Zhi-Shu Tang4, Jin-Ao Duan5.   

Abstract

Acetylsalicylic acid (Aspirin, ASA) is a famous drug for cardiovascular diseases in recent years. Effects of ASA dosage on the metabolic profile have not been fully understood. The purpose of our study is to establish a rapid and reliable method to quantify ASA metabolites in biological matrices, especially for glucuronide metabolites whose standards are not commercially available. Then we applied this method to evaluate the effects of ASA dosage on the metabolic and excretion profile of ASA metabolites in rat urine. Salicylic acid (SA), gentisic acid (GA) and salicyluric acid (SUA) were determined directly by UHPLC-MS/MS, while salicyl phenolic glucuronide (SAPG) and salicyluric acid phenolic glucuronide (SUAPG) were quantified indirectly by measuring the released SA and SUA from SAPG and SUAPG after β-glucuronidase digestion. SUA and SUAPG were the major metabolites of ASA in rat urine 24h after ASA administration, which accounted for 50% (SUA) and 26% (SUAPG). When ASA dosage was increased, the contributions dropped to 32% and 18%, respectively. The excretion of other three metabolites (GA, SA and SAPG) however showed remarkable increases by 16%, 6% and 4%, respectively. In addition, SUA and SUAPG were mainly excreted in the time period of 12-24h, while GA was excreted in the earlier time periods (0-4h and 4-8h). SA was mainly excreted in the time period of 0-4h and 12-24h. And the excretion of SAPG was equally distributed in the four time periods. We went further to show that the excretion of five metabolites in rat urine was delayed when ASA dosage was increased. In conclusion, we have developed a rapid and sensitive method to determine the five ASA metabolites (SA, GA, SUA, SAPG and SUAPG) in rat urine. We showed that ASA dosage could significantly influence the metabolic and excretion profile of ASA metabolites in rat urine.
Copyright © 2016 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Aspirin; Aspirin dosage; Metabolite; Urinary excretion; β-Glucuronidase

Mesh:

Substances:

Year:  2016        PMID: 28192718     DOI: 10.1016/j.jpba.2016.12.038

Source DB:  PubMed          Journal:  J Pharm Biomed Anal        ISSN: 0731-7085            Impact factor:   3.935


  6 in total

1.  Interaction of drugs amlodipine and paroxetine with the metabolizing enzyme CYP2B4: a molecular dynamics simulation study.

Authors:  Abbas Yousefpour; Hamid Modarress; Fatemeh Goharpey; Sepideh Amjad-Iranagh
Journal:  J Mol Model       Date:  2018-02-23       Impact factor: 1.810

Review 2.  Targeting inflammation: a potential approach for the treatment of depression.

Authors:  Shvetank Bhatt; Thangaraj Devadoss; Niraj Kumar Jha; Moushumi Baidya; Gaurav Gupta; Dinesh Kumar Chellappan; Sachin Kumar Singh; Kamal Dua
Journal:  Metab Brain Dis       Date:  2022-10-14       Impact factor: 3.655

3.  Novel absorbance peak of gentisic acid following the oxidation reaction.

Authors:  Sho Hosokawa; Kenichi Shukuya; Keisuke Sogabe; Yasukazu Ejima; Tatsuya Morinishi; Eiichiro Hirakawa; Hiroyuki Ohsaki; Tatsuo Shimosawa; Yasunori Tokuhara
Journal:  PLoS One       Date:  2020-04-29       Impact factor: 3.240

4.  Validation of an HPLC Method for the Simultaneous Quantification of Metabolic Reaction Products Catalysed by CYP2C11 Enzymes in Rat Liver Microsomes: In Vitro Inhibitory Effect of Salicylic Acid on CYP2C11 Enzyme.

Authors:  Hassan Salhab; Declan P Naughton; James Barker
Journal:  Molecules       Date:  2019-11-25       Impact factor: 4.411

5.  Metabolomic profiling for identification of metabolites and relevant pathways for taurine in hepatic stellate cells.

Authors:  Xin Deng; Xing-Qiu Liang; Fei-Guo Lu; Xiao-Fang Zhao; Lei Fu; Jian Liang
Journal:  World J Gastroenterol       Date:  2017-08-21       Impact factor: 5.742

6.  ASA Suppresses PGE2 in Plasma and Melanocytic Nevi of Human Subjects at Increased Risk for Melanoma.

Authors:  Amir Varedi; Hafeez Rahman; Dileep Kumar; Jonathan L Catrow; James E Cox; Tong Liu; Scott R Florell; Kenneth M Boucher; Nwanneka Okwundu; William J Burnett; Matthew W VanBrocklin; Douglas Grossman
Journal:  Pharmaceuticals (Basel)       Date:  2020-01-02
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.